Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and curcumin

3,4-dihydroxyphenylacetic acid has been researched along with curcumin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ku, BS; Li, XJ; Lin, YH; Ma, X; Xu, Y; Yao, HY; Zhang, YH1
Aruoma, OI; Datla, KP; Dexter, DT; Parkar, S; Rai, DK; Zbarsky, V1
Rajeswari, A; Sabesan, M1
Chang, XR; Li, J; Wang, L; Wu, DS1
Haider, S; Madiha, S1
Gao, XM; Hu, SM; Li, W; Ou, LN; Wang, JX; Zhang, DQ; Zhang, JJ; Zhong, GS1

Other Studies

6 other study(ies) available for 3,4-dihydroxyphenylacetic acid and curcumin

ArticleYear
The effects of curcumin on depressive-like behaviors in mice.
    European journal of pharmacology, 2005, Jul-25, Volume: 518, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Behavior, Animal; Brain; Curcumin; Dopamine; Dose-Response Relationship, Drug; Hindlimb Suspension; Hydroxyindoleacetic Acid; Imipramine; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase; Motor Activity; Norepinephrine; Serotonin; Swimming; Time Factors

2005
Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease.
    Free radical research, 2005, Volume: 39, Issue:10

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Curcumin; Disease Models, Animal; Dopamine; Flavanones; Flavonoids; Flavonols; Homovanillic Acid; Male; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Phenols; Quercetin; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase

2005
Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice.
    Inflammopharmacology, 2008, Volume: 16, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Curcumin; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Flavonoids; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Degeneration; Neurons; Parkinson Disease; Phenols; Polyphenols

2008
Analysis of anti-depressant potential of curcumin against depression induced male albino wistar rats.
    Brain research, 2016, 07-01, Volume: 1642

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Brain; Curcumin; Depressive Disorder; Disease Models, Animal; Dopamine; Male; Norepinephrine; Olfactory Bulb; Rats; Rats, Wistar; Serotonin; Swimming

2016
Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test.
    Metabolic brain disease, 2019, Volume: 34, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Choice Behavior; Corpus Striatum; Curcumin; Depression; Disease Models, Animal; Dopamine; Hippocampus; Hydroxyindoleacetic Acid; Neuronal Plasticity; Neuroprotective Agents; Rats; Rats, Wistar; Rotenone; Serotonin; Social Behavior

2019
[Effects of Guanyu capsule on the behavior and cerebral cortex monoamine neurotransmitters in depressive model of olfactory bulb damage rats].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2005, Volume: 30, Issue:10

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Biogenic Monoamines; Cerebral Cortex; Curcuma; Depression; Dopamine; Drugs, Chinese Herbal; Dryopteris; Male; Olfactory Bulb; Plants, Medicinal; Random Allocation; Rats; Rats, Sprague-Dawley; Serotonin

2005